HSA — authorised 14 January 2011
- Marketing authorisation holder: HOPE PHARMS
- Status: likely_approved
HSA authorised Sodium Nitrite on 14 January 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 14 January 2011.
HOPE PHARMS holds the Singaporean marketing authorisation.